+

WO1995029720A1 - Dispositif d'injection de securite - Google Patents

Dispositif d'injection de securite Download PDF

Info

Publication number
WO1995029720A1
WO1995029720A1 PCT/GB1995/000940 GB9500940W WO9529720A1 WO 1995029720 A1 WO1995029720 A1 WO 1995029720A1 GB 9500940 W GB9500940 W GB 9500940W WO 9529720 A1 WO9529720 A1 WO 9529720A1
Authority
WO
WIPO (PCT)
Prior art keywords
needle
medicament
housing
plunger
return
Prior art date
Application number
PCT/GB1995/000940
Other languages
English (en)
Inventor
William James Revell
Original Assignee
Pa Consulting Services Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pa Consulting Services Ltd. filed Critical Pa Consulting Services Ltd.
Priority to AU23134/95A priority Critical patent/AU2313495A/en
Publication of WO1995029720A1 publication Critical patent/WO1995029720A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/20—Automatic syringes, e.g. with automatically actuated piston rod, with automatic needle injection, filling automatically
    • A61M5/2053—Media being expelled from injector by pressurised fluid or vacuum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
    • A61M5/31501—Means for blocking or restricting the movement of the rod or piston
    • A61M2005/31508—Means for blocking or restricting the movement of the rod or piston provided on the piston-rod
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A61M5/32—Needles; Details of needles pertaining to their connection with syringe or hub; Accessories for bringing the needle into, or holding the needle on, the body; Devices for protection of needles
    • A61M5/3205—Apparatus for removing or disposing of used needles or syringes, e.g. containers; Means for protection against accidental injuries from used needles
    • A61M5/321—Means for protection against accidental injuries by used needles
    • A61M5/3243—Means for protection against accidental injuries by used needles being axially-extensible, e.g. protective sleeves coaxially slidable on the syringe barrel
    • A61M5/326—Fully automatic sleeve extension, i.e. in which triggering of the sleeve does not require a deliberate action by the user

Definitions

  • This invention relates to a device for, and method of, injection of medicaments into the body.
  • a number of devices for injection into the body are known, in which the injection needle is retained within the device in a storage position and deployed into a delivery position immediately prior to injection.
  • Such devices have the advantage of improved safety and also avoid the psychological deterrent effect of a readily visible needle. Accordingly, they are particularly suitable for use by non-medically trained personnel, especially for use as auto-injectors where the person operating the device injects his or her self.
  • Known devices for auto-injection are generally spring-operated. Examples of such devices include those disclosed in EP 0 516 473 and in GB 728,248. These publications describe injection devices in which one spring is used to deploy a hypodermic needle to a delivery position and to deliver an injection and a second spring is employed to retract the needle after the injection has been delivered. Accordingly, after the injection is made, work must be done in overcoming the resistance of the spring-operated means in order to retract the needle from its delivery position. This renders the device comparatively complicated and expensive to manufacture. Moreover, such devices are prone to causing muhiole punctures in the body being injected, due to oscillation of the needle. There exists therefore a need for improvements upon conventional devices of the type described above.
  • the invention provides a device for injection of a medicament into a human or animal body, comprising a housing having a medicament chamber containing a medicament to be injected, an injection needle communicating with the medicament chamber, a plunger in operable linkage to the needle, said plunger and needle being movable between a storage position in which the needle is fully retracted within the housing and a delivery position in which at least the tip of the needle projects beyond the housing, releasable retaining means for retaining the plunger in the storage position, means for applying a propulsive force to the plunger, the propulsive force being operative, when the retaining means are released, to propel the needle from the storage position to the delivery position and then to inject the medicament from the chamber into and through the injection needle, means for reducing the propulsive force, and injec.io.i needle return means operative to return the needle from the delivery position to the storage position after the injection of the medicament.
  • the propulsive force is supplied by a compressed fluid, most preferably by compressed gas.
  • the compressed fluid may be supplied from an external source (such as a cylinder of compressed air) or, advantageously, the fluid is compressed within and supplied by the device itself.
  • the means for reducing the propulsive force is capable of reducing the force to substantially zero.
  • the housing comprises two portions with an air-tight seal therebetween, the two portions being relatively movable from an unprimed to a primed position.
  • the two portions define an air-filled headspace of variable volume abutting the plunger, the volume of said headspace being greater in the unprimed position than in the primed position, such that relative priming movement of the two po ⁇ ions from the unprimed to the primed position compresses the air in the headspace, the plunger being retained in its storage position by the releasable retaining means.
  • Relative movement of the two portions may be by means of a sliding arrangement along an axis. This may be accomplished, for example, by simply pushing the two portions towards each other or by actuation of a lever.
  • one portion is located around the exterior of the other portion.
  • one portion is mounted on the other by means of a screw thread.
  • the device includes locking means operative to hold the two portions in the primed position.
  • locking means comprise an arm projecting from one portion which engages a co-operating recess on the other portion when the portions are in the primed position.
  • the releasable retaining means conveniently comprises a manually operable trigger mechanism. It is desirable that the releasable retaining means is releasable only when the device is in the primed position, thereby preventing premature release during priming of the device.
  • the releasable retaining means comprises a projection mounted on a resiliently deformable section of the plunger which projection engages a co-operating recess or cavity in the wall of the housing, the projection being disengaged from the co-operating recess or cavity by the action of a trigger button upon a trigger pin.
  • the plunger preferably comprises means for preventing rotation thereof within the housing.
  • means for preventing rotation thereof within the housing comprise a member on the plunger engaged between two guide pins mounted on the inner surface of the housing.
  • the plunger comprises two pistons: a first drive piston forms an air-tight seal with the inner surface of the wall of the housing, and a second medicament piston forms an air-tight seal with the inner surface of the wall the medicament chamber.
  • the drive piston serves to force the needle from the storage position to the delivery position.
  • the medicament piston serves to expel the medicament from the medicament chamber, through the needle, and into t ' r.s body.
  • the means for reducing the propulsive force is linked to the operation of the device in a timed relationship, such that the propulsive force is reduced only when all or substantially all the medicament has been discharged from the medicament chamber.
  • the plunger comprises a sharp and/or rigid projection which, when all or substantially all of the medicament has been expelled from the medicament chamber, contacts and ruptures a rupturable portion of the wall of the housing, allowing the air compressed in the headspace to escape therefrom, thereby removing the propulsive force.
  • a sleeve valve arrangement in which an outer sleeve is mounted on, and movable relative to, the housing.
  • the sleeve is movable between a closed position and an open position, such that in the closed position an aperture in the wall of the housing is covered by the outer sleeve, the sleeve preferably being retained in the closed position by retaining means.
  • the retaining means is released and the sleeve is moved to the open position, in which the aperture in the wall of the housing is uncovered, such that air compressed in the headspace of the nousing may escape through the aperture, thereby removing the propulsive force.
  • the sleeve valve is of the "bi-stable" variety.
  • a number of needle return means may be envisaged.
  • a return spring loaded between the wall of the drug chamber and the wall of the housing.
  • the arrangement is such that the return spring is compressed by the action of the plunger on the medicament chamber, such that the spring is compressed when the needle is in the delivery position.
  • the return spring tends to return to its former position, thereby retracting the needle within the housing.
  • a second headspace such that compression of the gas in the second headspace generates a return means for retracting the needle.
  • the second headspr.ee being located between the medicament chamber and the wall of the housing, such that advance of the medicament chamber to the primed position compresses air within the second headspace (there being no vents located in the wall of the housing), thereby providing the return means for retracting the needle.
  • the device is primed by the relative rotational movement of two portions of the housing with a helical thread in one portion engaged by the other, producing relative axial movement in response to the rotation, the two portions being locked in position by a locking detent on an outer sleeve of one of the portions engaging a co-operating recess on the other portion.
  • the helical thread is of non-uniform pitch, such that initial rotational movement produces greater relative axial movement of the two portions than subsequent rotational movement, which is resisted by the increased pressure of air within the headspace.
  • the device may be supplied to users in the primed or, preferably, the unprimed position. If supplied and stored in the unprimed position there is less chance of accidental discharge of the device. Moreover storage in the primed position, in which the components of the device are under stress, could lead to "creep" or deformation of synthetic plastics components.
  • the priming of the device results, in the preferred embodiment, of compression of air in a headspace abutting the plunger.
  • the compressed air tends to force the plunger along the longer axis of the housing.
  • the plunger however is held in place by releasable retaining means, comprising a projection mounted on a resilientlv deformable section of the plunger, the projection releasably engaging a cavity in the wall of the housing.
  • the needle end of the housing is placed against the skin in the spot to be injected.
  • the trigger is activated, depressing a trigger pin, disengaging the projection mounted on the resilientlv deformable section of the plunger from the cavity in the wall of the housing, thereby enabling the propulsive force of the compressed air in the headspace abutting the plunger to drive the plunger along the longer axis of the housing.
  • the drive piston thus advances the medicament chamber and needle to the delivery position where, since the housing has been placed in contact with the skin, the needle will penetrate the skin and enter the body. Air between the medicament chamber and the housing may be expelled by passage through one or more vents in the wall of the housing.
  • a return spring is compressed.
  • the propulsive force serves to advance the medicament piston within the medicament chamber, thereby expelling medicament from the chamber, through the needle and into the body.
  • a spike projecting from the plunger contacts and ruptures a rupturable portion in the wall of the housing, allowing the air compressed in the headspace to escape through the rupture, thereby reducing to zero the propulsive force acting on the plunger.
  • the return spring serves to force back the medicament chamber, thereby retracting the needle from the body back into the housing.
  • Forces resisting advance of the medicament chamber within the housing may include: static and sliding friction between the walls of the medicament chamber and the housing, resistance to the advance of the needle (whether caused by friction or entry into the subject's body), and overcoming the resistance of the return means.
  • Forces resisting expulsion of the medicament include static and sliding friction between the medicament piston and the walls of the medicament chamber. In addition it is preferred to generate sufficient pressure within the medicament chamber to give a significant flow rate of the medicament through the needle.
  • forces resisting expulsion of the medicament are optimally maximised (within reasonable levels) whilst those resisting advance of the needle and medicament chamber are optimally minimised.
  • resistance to flow of the medicament can be maximised by selection of a relatively long, fine bore needle (which selection has the advantage of minimising resistance of the subject's body to the needle and minimising the subject's discomfort).
  • Frictional forces between the medicament piston and the medicament chamber can be optimally maximised by the choice of materials, whilst those frictional forces between the medicament chamber and the housing may be optimally minimised by the selection of appropriate materials and lubricants.
  • the invention provides a method of delivering a liquid through a rupturable surface, comprising: placing adjacent to the rupturable surface a device comprising a housing having a chamber retaining the liquid to be delivered, a needle communicating with the chamber, a plunger in operable linkage to the needle, said position in which the needle is fully retracted within the housing and a delivery position in which at least the tip of the needle projects beyond the housing, releasable retaining means for retaining the plunger in the storage position, means for applying a propulsive force to the plunger, the propulsive force being operative, when the retaining means are released, to propel the needle from the storage position to the delivery position and then to deliver the liquid from the chamber, into and through the needle, means, for reducing the propulsive force, and needle return means operative to return the needle from the delivery position to the storage position after the delivery of the liquid; and activating the device so as to deliver the liquid.
  • the liquid is a medicament.
  • the rupturable surface is the skin of a human or animal body.
  • Figure 1 shows a longitudinal section of a first embodiment of the device
  • Figure 2a-e are representations showing operation of the first embodiment of the device in sequence
  • Figure 3 shows a longitudinal section of a second embodiment of the device
  • Figure 4a-e are representations showing operation of the second embodiment of the device in sequence.
  • a device ( Figure 1) for injection of a medicament into a human or animal body comprises a housing 10 of a moulded synthetic plastics material.
  • the housing 10 accommodates a medicament chamber 12 containing a medicament to be injected, a hollow-bore stainless steel needle 14 communicating with the medicament chamber 12, and a synthetic plastics material plunger 16 in operable linkage to the needle 14, the plunger 16 and the needle 14 being movable between a storage position ( Figure 2a) in which the needle is fully retracted within the housing and a delivery position ( Figures 2c-2d) in which at least the tip of the needle projects beyond the housing.
  • the device also includes releasable retaining means for retaining the plunger 16 in the storage position, the retaining means comprising a projection 18 mounted on a resiliently deformable section 20 of the plunger 16, the projection 18 engaging a recess 22 in the wall of the housing 10.
  • the device further comprises means for applying a propulsive force to the piunger 16, the propulsive force being operative, when the retaining means are released, to propel the needle 14 from the storage position (Figure 2a) to the delivery position ( Figure 2c) and then to inject the medicament from the chamber 12 into and through the needle 14 (Figure 2d), means for reducing the propulsive force, and needle return means operative to return the needle 14 from the delivery position to the storage position after injection of the medicament.
  • the housing comprises two portions ClOa. 10b) with a gasket 24 forming an air-tight seal therebetween.
  • the two portions 10a and 10b are relatively movable from an unprimed (Figure 2a) to a primed ( Figure 2b) position and define an air-filled headspace 26 of variable volume abutting the plunger 16.
  • the volume of the headspace 26 is greater in the unprimed position than in the primed position, such that relative priming movement of the two portions 10a and 10b from the unprimed to the primed position compresses the air in the headspace, the plunger 16 being retained in the storage position by the releasable retaining means.
  • the device is primed by relative rotational movement of the two portions 10a and 10b, with a helical thread on the outer surface of 10a engaged by 10b, producing relative axial movement in response to the rotation.
  • the helical thread on the portion 10a is of non-uniform pitch, such that initial rotational movement produces greater relative axial movement than subsequent rotational movement, which is resisted by the increased pressure of air within the headspace.
  • the two portions 10a and 10b are locked in the primed position by a locking detent 28 projecting from the portion 10a which engages with a snap fit a co-operating recess 30 in the portion 10b when the two portions 10a and 10b are moved into the primed position.
  • the portion 10b includes a manually operable trigger button 32 which, when the two portions 10a and 10b are moved into the primed position, becomes ⁇ ocatec adjacent to a trigger pin 34 retained within the recess 22 by an air-tight gasket 36. Actuation of the trigger button 32 depresses the trigger pin 34, deforming the resiliently deformable section 20 of the plunger 16, thereby disengaging the projection 18 from the recess 22.
  • the resiliently deformable section 20 and the projection 18 mounted thereon are shown in the released position as a dotted line in Figure 1.
  • the plunger 16 comprises a drive piston 38 forming an air-tight seal with the inner surface of the wall of the housing 10, and a medicament piston 40 forming an air-tight seal with the inner surface of the wall of the medicament chamber 12.
  • the plunger 16 also comprises a rigid, sharp projection 42 which, when substantially all of the medicament has been expelled from the medicament chamber 12, contacts and ruptures a rupturable diaphragm 44 in the wall of the housing 10.
  • the device further includes vents 46 and needle return means comprising a needle return spring 48 located between the medicament chamber 12 and the end wall of the housing 10.
  • the device is stored and supplied in the unprimed storage position shown in Figure 2a, in which the needle 14 is fully retracted within the housing 10.
  • the device is first primed by the user. Relative rotational movement of the two portions 10a and 10b produces relative axial movement of the portions 10a and 10b due to the screw thread engagement. Eventually the locking detent 28 engages co-operating recess 30 and the two portions are locked in the primed position ( Figure 2b), in which the volume of the headspace 26 is greatly reduced. The compressed gas therein thus provides a propulsive force.
  • Movement from the unprimed to the primed position also brings the trigger button 32 adjacent to the trigger pin 34.
  • the end of the housing 10 is placed agair?: the skin and the trigger button 34 is actuated.
  • This disengages the projection 18 from the co-operating recess 22, allowing the propulsive force of the gas compressed in the headspace 26 to act on the plunger 16 so as to propel the plunger 16 the medicament chamber 12 and the needle 14 from the storage position ( Figure 2b) to the delivery position ( Figure 2c), in which the needle 14 projects from the housing 10.
  • the medicament chamber 12 advances within the housing it tends to compress the return spring 48. Air displaced by the advance of the medicament chamber 12 passes through the vent 1 "- - .
  • the propulsive force still acting on the plunger 16 then causes the medicament piston 40 to advance within the medicament chamber 12, thereby expelling the medicament from the medicament chamber 12 and through the needle 14.
  • the device comprises a housing 10 comprising two portions 10a and 10b.
  • the housing 10 accommodates a medicament chamber 12, a hollow-bore stainless steel needle 14 communicating with the medicament chamber 12, and a synthetic plastics material plunger 16 in operable linkage to the needle 14, the plunger 16 and the needle 14 being movable between a storage position ( Figure 4a) in which the needle is fully retracted within the housing and a delivery position ( Figures 4c-4d) in which at least the tip of the needle 14 projects beyond the housing 10.
  • the device also includes releasable retaining means for retaining the plunger 16 in the storage position, the retaining means comprising a projection 18 mounted on a resiliently deformable section 20 (shown in dotted lines in Figure 3) of the plunger 16, the projection 18 engaging a co-operating recess 22 in the wall of the housing 10.
  • FIG. 3 there is a gasket 24 forming an air-tight seal between the two portions 10a and 10b, which are relatively movable from an unprimed position (Figure 4a) to a primed position ( Figure 4b) and define an air-filled headspace 26 of variable volume abutting the plunger 16.
  • the volume of the headspace 26 is greater in the unprimed position than in the primed position, such that relative priming movement of the two portions compresses the air in the headspace 26.
  • each detent 28 being mounted on a resiliently deformable arm 30 depending from the portion 10b, the detents 28 engaging co-operating recesses 34 in the portion 10a when the two portions 10a and 10b are moved into the primed position.
  • the resiliently deformable angled arms 30 are held in position by a cup-shaped guide member 40, the arms 30 being located in slots 46 in the side wall of the guide member 40, through which the locking detents 28 project to engage the co-operating recesses 34.
  • the portion 10b includes a manually operable trigger button 32 which, when the two portions 10a and 10b are moved into the primed position, becomes located adjacent to the projection 18. Actuation of the trigger button 32 depresses the projection 18, deforming the resiliently deformable section 20 of the plunger 16, thereby releasing the projection 18 from the co-operating recess 22.
  • the device further comprises fingers 36 projecting from the end of the plunger 16. When the device is primed, the fingers 36 pass through slots 38 in the end wall of the guide member 40.
  • the shape of the fingers 36 is such that they pass through the slots 38 during the priming of the device, but engage the end wall of the guide member 40 when the direction of the relative movement of fingers 36 and the guide member 40 is in the opposite direction.
  • the plunger 16 comprises two projecting arms 42 situated towards the end region of the plunger closer to the medicament chamber. These arms 42 are of resiliently deformable synthetic plastics material held in compression between the plunger and the wall of the housing 10a.
  • the device is primed by the user. Relative movement of the portions 10a and 10b results in the arrow-head locking detents 28 engaging co-operating recesses 34 ( Figure 4b). Air in the headspace 26 is greatly compressed, providing a propulsive force. Further, the trigger button 32 is brought into position adjacent to the projection 18 mounted on the resiliently deformable section 20 of the plunger 16.
  • the end of the housing 10a is placed against the skin and the trigger button 32 actuated. This disengages the projection 18 from the co-operating recess 22, allowing the gas compressed in the headspace to propel the plunger 16 and the needle 14 from the storage position to the delivery position ( Figure 4c).
  • Figure 4c When the medicament chamber 12 and the needle 14 are fully advanced, further movement of the medicament chamber 12 is resisted by contact with the housing 10. The propulsive force still acting on the plunger 16 then causes the plunger 16 to advance within the medicament chamber 12, thereby expelling the medicament from the medicament chamber 12.
  • the resiliently deformable projections 42 are brought, by the relative movement of the plunger 16 within the medicament chamber 12, into position adjacent co-operating recesses 44 in the wall of the chamber, and engage the recesses 44 with a snap fit.
  • the projecting fingers 36 engage the end wall of the guide member 40 and pull the guide member 40 slightly along the longer axis of the device.
  • the medicament chamber 12 and the needle 14 are also returned to their storage position.

Landscapes

  • Health & Medical Sciences (AREA)
  • Vascular Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)

Abstract

On décrit un dispositif d'injection d'un médicament dans le corps de l'homme ou de l'animal. Il comprend: un logement d'une chambre de médicament à injecter; une aiguille d'injection communiquant avec cette chambre; un plongeur, relié fonctionnellement à l'aiguille, les deux pouvant se déplacer entre une position de rangement, où l'aiguille est entièrement rétractée dans le logement, et une position d'administration où l'extrémité au moins de cette aiguille se projette hors dudit logement; un dispositif de rétention libérable qui retient le plongeur en position de rangement; un dispositif permettant d'appliquer au plongeur une force de propulsion qui agit, quand on libère le dispositif de rétention, pour propulser l'aiguille de la position de rangement vers la position d'administration puis pour injecter le médicament de la chambre dans l'aiguille d'injection et au-delà; un dispositif qui réduit la force de propulsion; et un dispositif de rétraction de cette aiguille qui intervient pour la retirer de la position d'administration à celle de rangement après injection du médicament.
PCT/GB1995/000940 1994-04-28 1995-04-25 Dispositif d'injection de securite WO1995029720A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU23134/95A AU2313495A (en) 1994-04-28 1995-04-25 Safety injection device

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9408500A GB9408500D0 (en) 1994-04-28 1994-04-28 Improvements in or relating to injection devices
GB9408500.8 1994-04-28

Publications (1)

Publication Number Publication Date
WO1995029720A1 true WO1995029720A1 (fr) 1995-11-09

Family

ID=10754316

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB1995/000940 WO1995029720A1 (fr) 1994-04-28 1995-04-25 Dispositif d'injection de securite

Country Status (3)

Country Link
AU (1) AU2313495A (fr)
GB (1) GB9408500D0 (fr)
WO (1) WO1995029720A1 (fr)

Cited By (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2755614A1 (fr) * 1996-11-13 1998-05-15 Dufort Maurice Louis Seringue a aiguille autoretractible monocoup
WO2000009186A3 (fr) * 1998-08-11 2000-05-18 Medi Ject Corp Pistolet a injection associe a une aiguille
WO2001012252A1 (fr) * 1999-08-13 2001-02-22 Imprint Pharmaceuticals Limited Dispositif d'injection
US6391003B1 (en) 1999-10-25 2002-05-21 Antares Pharma, Inc. Locking mechanism for a jet injector
EP1208858A1 (fr) * 2000-11-27 2002-05-29 Paolo Versini Appareil d'injection pour le traitement médical et cosmétique
WO2002083211A1 (fr) * 2001-04-13 2002-10-24 Penjet Corporation Injecteur modulaire sans aiguille a pression de gaz
WO2004054645A3 (fr) * 2002-12-17 2004-09-16 Cilag Ag Int Dispositif d'injection
US7018356B2 (en) 2002-10-31 2006-03-28 Wise Roger R Method and apparatus for adjusting the contents of a needle-less injector
FR2905273A1 (fr) * 2006-09-06 2008-03-07 Becton Dickinson France Soc Pa Dispositif d'injection automatique avec moyen de temporisation.
US7381201B2 (en) 2002-06-24 2008-06-03 Alza Corporation Reusable, spring driven autoinjector
EP1535639A4 (fr) * 2002-08-09 2009-01-07 Chang-Ming Yang Seringue
WO2009047247A1 (fr) * 2007-10-10 2009-04-16 Shl Group Ab Dispositif de distribution médical
WO2009114542A1 (fr) 2008-03-10 2009-09-17 Antares Pharma, Inc. Dispositif de sécurité pour injecteur
US7785292B2 (en) 2004-05-28 2010-08-31 Ethicon Endo-Surgery, Inc. Injection device
US7901377B1 (en) 2004-05-28 2011-03-08 Cilag Gmbh International Injection device
US8021335B2 (en) 2005-01-24 2011-09-20 Antares Pharma, Inc. Prefilled syringe jet injector
US8277414B2 (en) 2004-05-28 2012-10-02 Cilag Gmbh International Injection device
US8313464B2 (en) 2004-05-28 2012-11-20 Cilag Gmbh International Injection device
US8313463B2 (en) 2004-05-28 2012-11-20 Cilag Gmbh International Injection device
US8343110B2 (en) 2004-05-28 2013-01-01 Cilag Gmbh International Injection device
US8591457B2 (en) 2005-08-10 2013-11-26 Alza Corporation Method for making a needle-free jet injection drug delivery device
US8834419B2 (en) 2008-06-19 2014-09-16 Cilag Gmbh International Reusable auto-injector
US8845594B2 (en) 2008-06-19 2014-09-30 Cilag Gmbh International Auto-injector with filling means
US8915889B2 (en) 2008-08-05 2014-12-23 Antares Pharma, Inc. Multiple dosage injector
US8939958B2 (en) 2008-06-19 2015-01-27 Cilag Gmbh International Fluid transfer assembly for a syringe
US8945063B2 (en) 2009-03-20 2015-02-03 Antares Pharma, Inc. Hazardous agent injection system
US8968236B2 (en) 2005-04-06 2015-03-03 Cilag Gmbh International Injection device
US9028453B2 (en) 2008-06-19 2015-05-12 Cilag Gmbh International Reusable auto-injector
US9028451B2 (en) 2006-06-01 2015-05-12 Cilag Gmbh International Injection device
US9072833B2 (en) 2006-06-01 2015-07-07 Cilag Gmbh International Injection device
US9144648B2 (en) 2006-05-03 2015-09-29 Antares Pharma, Inc. Injector with adjustable dosing
US9220660B2 (en) 2011-07-15 2015-12-29 Antares Pharma, Inc. Liquid-transfer adapter beveled spike
US9333309B2 (en) 2002-02-11 2016-05-10 Antares Pharma, Inc. Intradermal injector
US9358346B2 (en) 2005-08-30 2016-06-07 Cilag Gmbh International Needle assembly for a prefilled syringe system
US9364610B2 (en) 2012-05-07 2016-06-14 Antares Pharma, Inc. Injection device with cammed ram assembly
US9446195B2 (en) 2011-07-15 2016-09-20 Antares Pharma, Inc. Injection device with cammed ram assembly
US9649441B2 (en) 2005-04-06 2017-05-16 Cilag Gmbh International Injection device (bayonet cap removal)
US9675757B2 (en) 2004-05-28 2017-06-13 Cilag Gmbh International Injection device
US9675758B2 (en) 2004-05-28 2017-06-13 Cilag Gmbh International Injection device
US9682194B2 (en) 2008-06-19 2017-06-20 Cilag Gmbh International Re-useable auto-injector with filling means
US9707354B2 (en) 2013-03-11 2017-07-18 Antares Pharma, Inc. Multiple dosage injector with rack and pinion dosage system
US9731080B2 (en) 2005-04-06 2017-08-15 Cilag Gmbh International Injection device
US9744302B2 (en) 2013-02-11 2017-08-29 Antares Pharma, Inc. Needle assisted jet injection device having reduced trigger force
US9757520B2 (en) 2006-06-01 2017-09-12 Cilag Gmbh International Injection device
US9770558B2 (en) 2005-09-27 2017-09-26 Cilag Gmbh International Auto-injection device with needle protecting cap having outer and inner sleeves
US9808582B2 (en) 2006-05-03 2017-11-07 Antares Pharma, Inc. Two-stage reconstituting injector
US9895493B2 (en) 2004-05-28 2018-02-20 Cilag Gmbh International Injection device
US9950125B2 (en) 2012-04-06 2018-04-24 Antares Pharma, Inc. Needle assisted jet injection administration of testosterone compositions
US10709849B2 (en) 2013-06-11 2020-07-14 Cilag Gmbh International Guide for an injection device
US10799646B2 (en) 2013-06-11 2020-10-13 Cilag Gmbh International Injection device
US11123492B2 (en) 2013-06-11 2021-09-21 Cilag Gmbh International Injection device
US11173255B2 (en) 2013-06-11 2021-11-16 Cilag Gmbh International Injection device
EP3981451A1 (fr) 2015-01-21 2022-04-13 Antares Pharma, Inc. Dispositif d'injection doté d'un dosage variable
US11878156B2 (en) 2015-04-20 2024-01-23 Antares Pharma, Inc. Injection device

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH518102A (de) * 1969-11-14 1972-01-31 Georg A Henke Gmbh Selbsttätiges Injektionsgerät
US3977402A (en) * 1975-03-25 1976-08-31 William Floyd Pike Injection apparatus and method with automatic aspiration feature
US4717384A (en) * 1987-01-15 1988-01-05 Pneu Dart Inc. Pneumatic hypodermic syringe pole
US5049133A (en) * 1989-01-24 1991-09-17 Villen Pascual Joee A Single-use safety syringe
WO1992019296A2 (fr) * 1991-04-29 1992-11-12 Kramer George C Systeme et procede d'administration vasculaire rapide de medicament
EP0516473A1 (fr) * 1991-05-30 1992-12-02 Owen Mumford Limited Dispositif d'injection automatique

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH518102A (de) * 1969-11-14 1972-01-31 Georg A Henke Gmbh Selbsttätiges Injektionsgerät
US3977402A (en) * 1975-03-25 1976-08-31 William Floyd Pike Injection apparatus and method with automatic aspiration feature
US4717384A (en) * 1987-01-15 1988-01-05 Pneu Dart Inc. Pneumatic hypodermic syringe pole
US5049133A (en) * 1989-01-24 1991-09-17 Villen Pascual Joee A Single-use safety syringe
WO1992019296A2 (fr) * 1991-04-29 1992-11-12 Kramer George C Systeme et procede d'administration vasculaire rapide de medicament
EP0516473A1 (fr) * 1991-05-30 1992-12-02 Owen Mumford Limited Dispositif d'injection automatique

Cited By (101)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2755614A1 (fr) * 1996-11-13 1998-05-15 Dufort Maurice Louis Seringue a aiguille autoretractible monocoup
US6565553B2 (en) 1998-08-11 2003-05-20 Antares Pharma, Inc. Needle assisted jet injector
WO2000009186A3 (fr) * 1998-08-11 2000-05-18 Medi Ject Corp Pistolet a injection associe a une aiguille
US7776015B2 (en) 1998-08-11 2010-08-17 Antares Pharma Inc. Needle assisted jet injector
US6428528B2 (en) 1998-08-11 2002-08-06 Antares Pharma, Inc. Needle assisted jet injector
US6746429B2 (en) 1998-08-11 2004-06-08 Antares Pharma, Inc. Needle assisted jet injector
WO2001012252A1 (fr) * 1999-08-13 2001-02-22 Imprint Pharmaceuticals Limited Dispositif d'injection
US6391003B1 (en) 1999-10-25 2002-05-21 Antares Pharma, Inc. Locking mechanism for a jet injector
EP1208858A1 (fr) * 2000-11-27 2002-05-29 Paolo Versini Appareil d'injection pour le traitement médical et cosmétique
WO2002083211A1 (fr) * 2001-04-13 2002-10-24 Penjet Corporation Injecteur modulaire sans aiguille a pression de gaz
AU2001253458B2 (en) * 2001-04-13 2005-10-27 Penjet Corporation Modular gas-pressured needle-less injector
AU2001253458C1 (en) * 2001-04-13 2006-05-18 Penjet Corporation Modular gas-pressured needle-less injector
US9737670B2 (en) 2002-02-11 2017-08-22 Antares Pharma, Inc. Intradermal injector
US9333309B2 (en) 2002-02-11 2016-05-10 Antares Pharma, Inc. Intradermal injector
US7381201B2 (en) 2002-06-24 2008-06-03 Alza Corporation Reusable, spring driven autoinjector
EP1535639A4 (fr) * 2002-08-09 2009-01-07 Chang-Ming Yang Seringue
US7018356B2 (en) 2002-10-31 2006-03-28 Wise Roger R Method and apparatus for adjusting the contents of a needle-less injector
KR101120412B1 (ko) 2002-12-17 2012-03-16 칠락 게엠베하 인테르나티오날 주사 장치
EP2289582A3 (fr) * 2002-12-17 2016-11-23 Cilag GmbH International Dispositif d'injection ayant un méchanisme de libération pour retarder la libération de la seringue
JP2006510465A (ja) * 2002-12-17 2006-03-30 シラグ・エイジー・インターナショナル 注入器械
NO339006B1 (no) * 2002-12-17 2016-11-07 Cilag Gmbh Int Injeksjonsanordning
AU2003294124B2 (en) * 2002-12-17 2009-11-26 Cilag Gmbh International Injection device
WO2004054645A3 (fr) * 2002-12-17 2004-09-16 Cilag Ag Int Dispositif d'injection
CN102580197A (zh) * 2002-12-17 2012-07-18 西拉格国际有限公司 注射装置
EA008081B1 (ru) * 2002-12-17 2007-02-27 Цилаг Аг Интернэшнл Устройство для инъекций
US9675757B2 (en) 2004-05-28 2017-06-13 Cilag Gmbh International Injection device
US9895493B2 (en) 2004-05-28 2018-02-20 Cilag Gmbh International Injection device
US7901377B1 (en) 2004-05-28 2011-03-08 Cilag Gmbh International Injection device
US7785292B2 (en) 2004-05-28 2010-08-31 Ethicon Endo-Surgery, Inc. Injection device
US8277414B2 (en) 2004-05-28 2012-10-02 Cilag Gmbh International Injection device
US8313464B2 (en) 2004-05-28 2012-11-20 Cilag Gmbh International Injection device
US8313463B2 (en) 2004-05-28 2012-11-20 Cilag Gmbh International Injection device
US8343110B2 (en) 2004-05-28 2013-01-01 Cilag Gmbh International Injection device
US9675758B2 (en) 2004-05-28 2017-06-13 Cilag Gmbh International Injection device
US10478560B2 (en) 2005-01-24 2019-11-19 Antares Pharma, Inc. Prefilled syringe injector
US9180259B2 (en) 2005-01-24 2015-11-10 Antares Pharma, Inc. Prefilled syringe jet injector
EP3495009A1 (fr) 2005-01-24 2019-06-12 Antares Pharma, Inc. Injecteur à jet de seringue préremplie
US9629959B2 (en) 2005-01-24 2017-04-25 Antares Pharma, Inc. Prefilled syringe jet injector
US8021335B2 (en) 2005-01-24 2011-09-20 Antares Pharma, Inc. Prefilled syringe jet injector
US8562564B2 (en) 2005-01-24 2013-10-22 Antares Pharma, Inc. Prefilled syringe jet injector
US11446441B2 (en) 2005-01-24 2022-09-20 Antares Pharma, Inc. Prefilled syringe injector
US9731080B2 (en) 2005-04-06 2017-08-15 Cilag Gmbh International Injection device
US9649441B2 (en) 2005-04-06 2017-05-16 Cilag Gmbh International Injection device (bayonet cap removal)
US8968236B2 (en) 2005-04-06 2015-03-03 Cilag Gmbh International Injection device
US8591457B2 (en) 2005-08-10 2013-11-26 Alza Corporation Method for making a needle-free jet injection drug delivery device
US8998881B2 (en) 2005-08-10 2015-04-07 Alza Corporation Method for delivering drugs to tissue under microjet propulsion
US9358346B2 (en) 2005-08-30 2016-06-07 Cilag Gmbh International Needle assembly for a prefilled syringe system
US9770558B2 (en) 2005-09-27 2017-09-26 Cilag Gmbh International Auto-injection device with needle protecting cap having outer and inner sleeves
US9808582B2 (en) 2006-05-03 2017-11-07 Antares Pharma, Inc. Two-stage reconstituting injector
US9144648B2 (en) 2006-05-03 2015-09-29 Antares Pharma, Inc. Injector with adjustable dosing
US11547808B2 (en) 2006-05-03 2023-01-10 Antares Pharma, Inc. Two-stage reconstituting injector
US10688250B2 (en) 2006-05-03 2020-06-23 Antares Pharma, Inc. Two-stage reconstituting injector
US9028451B2 (en) 2006-06-01 2015-05-12 Cilag Gmbh International Injection device
US9072833B2 (en) 2006-06-01 2015-07-07 Cilag Gmbh International Injection device
US9757520B2 (en) 2006-06-01 2017-09-12 Cilag Gmbh International Injection device
FR2905273A1 (fr) * 2006-09-06 2008-03-07 Becton Dickinson France Soc Pa Dispositif d'injection automatique avec moyen de temporisation.
US9486582B2 (en) 2006-09-06 2016-11-08 Becton Dickinson France S.A.S. Automatic injection device with temporizing means
US8435215B2 (en) 2006-09-06 2013-05-07 Becton, Dickinson And Company Automatic injection device with temporizing means
US7976514B2 (en) 2006-09-06 2011-07-12 Becton, Dickinson And Company Automatic injection device with temporizing means
WO2008029280A3 (fr) * 2006-09-06 2008-11-13 Becton Dickinson France Dispositif d'injection automatique équipé de moyens de temporisation
WO2009047247A1 (fr) * 2007-10-10 2009-04-16 Shl Group Ab Dispositif de distribution médical
EP3636301A1 (fr) 2008-03-10 2020-04-15 Antares Pharma, Inc. Dispositif de sécurité d'injecteur
EP2990067A1 (fr) 2008-03-10 2016-03-02 Antares Pharma, Inc. Dispositif de sécurité d'injecteur
WO2009114542A1 (fr) 2008-03-10 2009-09-17 Antares Pharma, Inc. Dispositif de sécurité pour injecteur
US9028453B2 (en) 2008-06-19 2015-05-12 Cilag Gmbh International Reusable auto-injector
US8845594B2 (en) 2008-06-19 2014-09-30 Cilag Gmbh International Auto-injector with filling means
US8834419B2 (en) 2008-06-19 2014-09-16 Cilag Gmbh International Reusable auto-injector
US9682194B2 (en) 2008-06-19 2017-06-20 Cilag Gmbh International Re-useable auto-injector with filling means
US8939958B2 (en) 2008-06-19 2015-01-27 Cilag Gmbh International Fluid transfer assembly for a syringe
US8915889B2 (en) 2008-08-05 2014-12-23 Antares Pharma, Inc. Multiple dosage injector
US9750881B2 (en) 2009-03-20 2017-09-05 Antares Pharma, Inc. Hazardous agent injection system
US10555954B2 (en) 2009-03-20 2020-02-11 Antares Pharma, Inc. Hazardous agent injection system
US8945063B2 (en) 2009-03-20 2015-02-03 Antares Pharma, Inc. Hazardous agent injection system
US11497753B2 (en) 2009-03-20 2022-11-15 Antares Pharma, Inc. Hazardous agent injection system
US10568809B2 (en) 2011-07-15 2020-02-25 Ferring B.V. Liquid-transfer adapter beveled spike
US9446195B2 (en) 2011-07-15 2016-09-20 Antares Pharma, Inc. Injection device with cammed ram assembly
US12179007B2 (en) 2011-07-15 2024-12-31 Antares Pharma, Inc. Injection device with cammed ram assembly
US10279131B2 (en) 2011-07-15 2019-05-07 Antares Pharma, Inc. Injection device with cammed RAM assembly
US9220660B2 (en) 2011-07-15 2015-12-29 Antares Pharma, Inc. Liquid-transfer adapter beveled spike
US10821072B2 (en) 2012-04-06 2020-11-03 Antares Pharma, Inc. Needle assisted jet injection administration of testosterone compositions
US11771646B2 (en) 2012-04-06 2023-10-03 Antares Pharma, Inc. Needle assisted jet injection administration of testosterone compositions
US9950125B2 (en) 2012-04-06 2018-04-24 Antares Pharma, Inc. Needle assisted jet injection administration of testosterone compositions
US9364610B2 (en) 2012-05-07 2016-06-14 Antares Pharma, Inc. Injection device with cammed ram assembly
US11446440B2 (en) 2012-05-07 2022-09-20 Antares Pharma, Inc. Needle assisted injection device having reduced trigger force
US12220560B2 (en) 2012-05-07 2025-02-11 Antares Pharma, Inc. Needle assisted injection device having reduced trigger force
US12171986B2 (en) 2012-05-07 2024-12-24 Antares Pharma, Inc. Injection device with cammed ram assembly
US10905827B2 (en) 2012-05-07 2021-02-02 Antares Pharma, Inc. Injection device with cammed ram assembly
US9364611B2 (en) 2012-05-07 2016-06-14 Antares Pharma, Inc. Needle assisted jet injection device having reduced trigger force
US10357609B2 (en) 2012-05-07 2019-07-23 Antares Pharma, Inc. Needle assisted jet injection device having reduced trigger force
US9744302B2 (en) 2013-02-11 2017-08-29 Antares Pharma, Inc. Needle assisted jet injection device having reduced trigger force
US11813435B2 (en) 2013-02-11 2023-11-14 Antares Pharma, Inc. Needle assisted injection device having reduced trigger force
US10881798B2 (en) 2013-02-11 2021-01-05 Antares Pharma, Inc. Needle assisted injection device having reduced trigger force
US10610649B2 (en) 2013-03-11 2020-04-07 Antares Pharma, Inc. Multiple dosage injector with rack and pinion dosage system
US11628260B2 (en) 2013-03-11 2023-04-18 Antares Pharma, Inc. Multiple dosage injector with rack and pinion dosage system
US9707354B2 (en) 2013-03-11 2017-07-18 Antares Pharma, Inc. Multiple dosage injector with rack and pinion dosage system
US11173255B2 (en) 2013-06-11 2021-11-16 Cilag Gmbh International Injection device
US11123492B2 (en) 2013-06-11 2021-09-21 Cilag Gmbh International Injection device
US10799646B2 (en) 2013-06-11 2020-10-13 Cilag Gmbh International Injection device
US10709849B2 (en) 2013-06-11 2020-07-14 Cilag Gmbh International Guide for an injection device
EP3981451A1 (fr) 2015-01-21 2022-04-13 Antares Pharma, Inc. Dispositif d'injection doté d'un dosage variable
US11878156B2 (en) 2015-04-20 2024-01-23 Antares Pharma, Inc. Injection device

Also Published As

Publication number Publication date
AU2313495A (en) 1995-11-29
GB9408500D0 (en) 1994-06-22

Similar Documents

Publication Publication Date Title
WO1995029720A1 (fr) Dispositif d'injection de securite
US20210138152A1 (en) Devices, systems and methods for medicament delivery
US6074370A (en) Safety syringe
EP1755709B1 (fr) Dispositif d'injection
JP3486189B2 (ja) 安全注射器
JP3487856B2 (ja) 無針注射器
US9737670B2 (en) Intradermal injector
US9149579B2 (en) Devices, systems and methods for medicament delivery
US5620421A (en) Syringe injector system
US5846233A (en) Coupling device for medical injection system
US6206857B1 (en) Syringe with needle retraction arrangement
US20070049873A1 (en) Impulse chamber for jet delivery device
US20130211330A1 (en) Medical Injection Device
AU2004298717A1 (en) Nozzle device with skin stretching means
WO1994013342A1 (fr) Dispositif adapte pour l'administration intradermique automatique d'un medicament
EP3240594B1 (fr) Dispositif d'administration de médicament doté d'un mécanisme de déclenchement hydraulique
JP2005536273A (ja) 脱気流体で無針注入する装置
US20060027285A1 (en) Injection device with re-usable pressure generating means
US20250127989A1 (en) Medical Injections

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AM AT AU BB BG BR BY CA CH CN CZ DE DK EE ES FI GB GE HU IS JP KE KG KP KR KZ LK LR LT LU LV MD MG MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TT UA UG US UZ VN

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): KE MW SD SZ UG AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

NENP Non-entry into the national phase

Ref country code: CA

122 Ep: pct application non-entry in european phase
点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载